Rich Pharmaceuticals, Inc. Debt Conversion, Converted Instrument, Rate
Rich Pharmaceuticals, Inc. reported Debt Conversion, Converted Instrument, Rate of 58.00% for the 12-month period ending 2014-03-31, per its 10-K filed 2014-07-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2014-07-15
- Rich Pharmaceuticals, Inc. debt conversion, converted instrument, rate for fiscal 2014 was 58.00%.
| Period end | Debt Conversion, Converted Instrument, Rate 12 month |
|---|---|
| 2014-03-31 | 58.00% 10-K · filed 2014-07-15 |